Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide
Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamideHaploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide, Published online: 16 January 2018; doi:10.1038/s41409-017-0077-1Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide
Source: Bone Marrow Transplantation - Category: Hematology Authors: Haydar Frangoul Misty Evans Julie Isbell Katie Bruce Jennifer Domm Source Type: research
More News: Bone Marrow Transplant | Hematology | Sickle Cell Anemia | Stem Cell Therapy | Stem Cells | Transplants